DORMONOCT

This brand name is authorized in Netherlands, South Africa

Active ingredients

The drug DORMONOCT contains one active pharmaceutical ingredient (API):

1 Loprazolam UNII VKF8383J65 - LOPRAZOLAM MESILATE

Benzodiazepines have a widespread action as a result of their enhancing the release of gamma-aminobutyric acid (GABA). They are effective as anti-convulsants, muscle relaxants, anti-anxiety agents, pre-medications and sedative hypnotics. Loprazolam is indicated for the short-term treatment of insomnia including difficulty in falling asleep and/or frequent nocturnal awakenings. Read about Loprazolam

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DORMONOCT Tablet	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05CD11	Loprazolam	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives
Discover more medicines within N05CD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 19534
Country: ZA	Health Products Regulatory Authority	Identifier(s): Q/2.2/355